Evaluation of butorphanol-azaperone-medetomidine in captive cheetah (Acinonyx jubatus) immobilization.
Acinonyx
/ physiology
Anesthesia
/ veterinary
Anesthetics, Combined
Animals
Animals, Zoo
/ physiology
Azaperone
/ administration & dosage
Butorphanol
/ administration & dosage
Female
Heart Rate
/ drug effects
Hypnotics and Sedatives
/ administration & dosage
Immobilization
/ veterinary
Male
Medetomidine
/ administration & dosage
Prospective Studies
Respiratory Rate
/ drug effects
Treatment Outcome
Azaperone
BAM
butorphanol
cheetah
immobilisation
medetomidine
Journal
Veterinary anaesthesia and analgesia
ISSN: 1467-2995
Titre abrégé: Vet Anaesth Analg
Pays: United States
ID NLM: 100956422
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
28
03
2017
revised:
28
07
2018
accepted:
13
09
2018
pubmed:
18
12
2018
medline:
8
1
2019
entrez:
18
12
2018
Statut:
ppublish
Résumé
The butorphanol-azaperone-medetomidine fixed-dose combination (BAM, respectively, 30-12-12 mg mL Prospective, clinical trial. Twelve cheetahs (six males and six females, weighing 37-57 kg) housed in enclosures, were immobilized at Hoedspruit Endangered Species Centre in the Republic of South Africa. BAM volume dose rate was 0.009-0.014 mL kg The inductions were calm and smooth and mean induction time was 4.0 ± 1.1 minutes. Heart rate (50 ± 9 beats minute and clinical relevance BAM proved to be a reliable and cardiovascular stable drug combination for immobilization of cheetahs.
Identifiants
pubmed: 30554889
pii: S1467-2987(18)30257-5
doi: 10.1016/j.vaa.2018.09.038
pii:
doi:
Substances chimiques
Anesthetics, Combined
0
Hypnotics and Sedatives
0
Azaperone
19BV78AK7W
Medetomidine
MR15E85MQM
Butorphanol
QV897JC36D
Types de publication
Clinical Trial, Veterinary
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
90-95Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2018 Association of Veterinary Anaesthetists and American College of Veterinary Anesthesia and Analgesia. Published by Elsevier Ltd. All rights reserved.